Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-123291
Filing Date
2024-11-07
Accepted
2024-11-07 16:06:25
Documents
64
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bold-20240930.htm   iXBRL 10-Q 1730299
2 EX-10.1 bold-ex10_1.htm EX-10.1 65420
3 EX-31.1 bold-ex31_1.htm EX-31.1 15351
4 EX-31.2 bold-ex31_2.htm EX-31.2 15510
5 EX-32.1 bold-ex32_1.htm EX-32.1 13135
  Complete submission text file 0000950170-24-123291.txt   6808205

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bold-20240930.xsd EX-101.SCH 920483
67 EXTRACTED XBRL INSTANCE DOCUMENT bold-20240930_htm.xml XML 1108756
Mailing Address 9880 CAMPUS POINT DRIVE SUITE 120 SAN DIEGO CA 92121
Business Address 9880 CAMPUS POINT DRIVE SUITE 120 SAN DIEGO CA 92121 (858) 766-9912
Boundless Bio, Inc. (Filer) CIK: 0001782303 (see all company filings)

EIN.: 830751369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41989 | Film No.: 241435568
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)